142 related articles for article (PubMed ID: 11086370)
1. Regional variations in the incidence of end-stage renal failure in Japan.
Usami T; Koyama K; Takeuchi O; Morozumi K; Kimura G
JAMA; 2000 Nov 22-29; 284(20):2622-4. PubMed ID: 11086370
[TBL] [Abstract][Full Text] [Related]
2. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
[TBL] [Abstract][Full Text] [Related]
3. Different regional dynamics of end-stage renal disease in Japan by different causes.
Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
[TBL] [Abstract][Full Text] [Related]
4. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.
Usami T; Nakao N; Fukuda M; Takeuchi O; Kamiya Y; Yoshida A; Kimura G
Kidney Int; 2003 Oct; 64(4):1445-9. PubMed ID: 12969164
[TBL] [Abstract][Full Text] [Related]
5. Low birth weight and end-stage renal disease: demographic analysis by region in Japan.
Ichikawa T; Fukuda M; Wakamatsu-Yamanaka T; Sato R; Naito T; Togawa H; Sasakawa Y; Tomonari T; Mizuno M; Miura T; Kato Y; Ono M; Shirasawa Y; Ito A; Yoshida A; Kimura G
Clin Exp Nephrol; 2012 Aug; 16(4):596-603. PubMed ID: 22302087
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in end-stage renal disease and amount of protein intake in Japan.
Motokawa M; Fukuda M; Muramatsu W; Sengo K; Kato N; Usami T; Yoshida A; Kimura G
J Ren Nutr; 2007 Mar; 17(2):118-25. PubMed ID: 17321951
[TBL] [Abstract][Full Text] [Related]
7. Geographic differences in the increasing ESRD rate have disappeared in Japan.
Wakamatsu-Yamanaka T; Fukuda M; Sato R; Naito T; Togawa H; Tomonari T; Kato Y; Miura T; Mizuno M; Ichikawa T; Miyagi S; Shirasawa Y; Ito A; Yoshida A; Kimura G
Clin Exp Nephrol; 2011 Oct; 15(5):708-713. PubMed ID: 21638004
[TBL] [Abstract][Full Text] [Related]
8. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
[TBL] [Abstract][Full Text] [Related]
10. [Incidence of end-stage renal disease in Ile de France: a prospective epidemiological survey].
Jungers P; Massy Z; Man NK; Labrunie M; Taupin P; Guin E; Landais P
Presse Med; 2000 Mar; 29(11):589-92. PubMed ID: 10776412
[TBL] [Abstract][Full Text] [Related]
11. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
Hattori S; Yosioka K; Honda M; Ito H;
Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
[TBL] [Abstract][Full Text] [Related]
12. Renal outcomes in chronic kidney disease.
Iseki K
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
[TBL] [Abstract][Full Text] [Related]
13. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
[TBL] [Abstract][Full Text] [Related]
14. Prediction of end-stage renal disease patient population in Japan by system dynamics model.
Motohashi Y; Nishi S
Int J Epidemiol; 1991 Dec; 20(4):1032-6. PubMed ID: 1800400
[TBL] [Abstract][Full Text] [Related]
15. Hip Fracture Trends in Japanese Dialysis Patients, 2008-2013.
Wakasugi M; Kazama JJ; Wada A; Hamano T; Masakane I; Narita I
Am J Kidney Dis; 2018 Feb; 71(2):173-181. PubMed ID: 29162337
[TBL] [Abstract][Full Text] [Related]
16. Association between the rate of low-birth weight newborns and the incidence of end-stage renal disease in 47 prefectures in Japan.
Imasawa T; Nakazato T
Clin Exp Nephrol; 2012 Aug; 16(4):617-21. PubMed ID: 22358612
[TBL] [Abstract][Full Text] [Related]
17. Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.
Usami T; Kimura G
Clin Exp Nephrol; 2006 Mar; 10(1):8-12. PubMed ID: 16544172
[TBL] [Abstract][Full Text] [Related]
18. Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care.
Zarkowsky DS; Hicks CW; Arhuidese I; Canner JK; Obeid T; Qazi U; Schneider E; Abularrage CJ; Black JH; Freischlag JA; Malas MB
JAMA Surg; 2015 Aug; 150(8):764-70. PubMed ID: 26107005
[TBL] [Abstract][Full Text] [Related]
19. Current Trend of Pediatric Renal Replacement Therapy in Japan.
Hattori M
Contrib Nephrol; 2018; 196():223-228. PubMed ID: 30041231
[TBL] [Abstract][Full Text] [Related]
20. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
McDonald SP; Russ GR; Kerr PG; Collins JF;
Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
